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Introduction
Hemifacial spasm is a peripheral myoclonus of the VIIth cranial nerve. It is characterized by paroxysmal contraction of the muscles of facial expression, and it exists in both primary and secondary forms:
• Primary hemifacial spasm is caused by vascular compression of the facial nerve by aberrant or ectatic vessels as the nerve exits the brainstem.
• Secondary hemifacial spasm is caused by several pathologies, including brainstem lesions, cerebellopontine angle tumors, infections, arteriovenous malformations, and structural anomalies. 1 In rare cases, hemifacial spasm is caused by middle ear pathology.
Primary hemifacial spasm is far more common than secondary spasm. 2 In this article, we present a case of recurrent cholesteatoma and tympanic segment fallopian canal dehiscence that manifested as hemifacial spasm.
Case report
A 90-year-old man presented to our office with a 6-month history of right-sided hemifacial spasm. His history was significant for a right-sided tympanomastoidectomy for cholesteatoma 6 years earlier. For his current complaint, he was initially seen by a primary care physician, who then referred him to a neurologist. Computed tomographic angiography (CTA) was performed to look for vascular compression of the facial nerve. However, the CTA was significant only for right middle ear opacification without mastoid involvement (figure). The patient was then referred to our otolaryngology clinic.
The patient described the spasms as a violent twitching of the entire right side of his face. He noted that they had become progressively more frequent. He denied otalgia, otorrhea, and vertigo. Although he had had a significant mixed hearing loss for many years, it had remained unchanged during this time. He had not experienced any facial spasms in the past.
On otomicroscopy of the right ear, recurrent middle ear disease was found to be present. There was no identifiable tympanic membrane to the level of the annulus, and the middle ear space had been filled with substantial squamous debris. During an attempt at in-office debridement, the spasm was triggered by manipulation of the debris. This raised a suspicion that the cause of the spasm was a dehiscent facial nerve with compression. Options were discussed with the patient and, ultimately, middle ear exploration was agreed upon.
The patient was taken to the operating room for a middle ear exploration. A facial nerve monitor used throughout the surgery demonstrated significant, spontaneous stimulation of the nerve. Removal of the middle ear debris revealed a completely dehiscent tym- Sohal, Karter, eiSen panic segment with keratin debris abutting the facial nerve. The overlaying squamous debris and matrix were carefully dissected off, and the facial nerve was stimulated at the conclusion of the dissection.
We found no extension of the cholesteatoma to the mastoid. The cholesteatoma appeared to involve both the incus and the malleus, but the stapes was intact and mobile. The tympanic membrane was reconstructed with temporalis fascia and conchal cartilage, and a partial ossicular prosthesis was placed. In the postanesthesia care unit, the patient exhibited full facial nerve function, as his House-Brackmann score was 1/6. The final diagnosis was hemifacial spasm secondary to cholesteatoma.
At follow-up 14 months later, we found no clinical or radiologic evidence of recurrent middle ear disease or facial spasm. Otomicroscopy demonstrated a wellhealed tympanoplasty, and audiometry demonstrated a stable high-frequency sensorineural hearing loss without any significant conductive component.
Discussion
Hemifacial spasm is a rare condition that manifests as paroxysmal clonic or tonic contractions of the muscles innervated by the VIIth cranial nerve. It is the most common peripheral myoclonic disease. 1 The reported incidence of primary hemifacial spasm is 11 per 100,000 population, with a female-to-male ratio of 2:1. Secondary hemifacial spasm has several reported causes, including brainstem lesions, cerebellopontine angle tumors, arachnoid cysts/granulations, infection, and parotid tumors. Middle ear pathology in association with a dehiscent facial nerve can also cause hemifacial spasm. 3 This has been reported in the past regarding otitis media, but to the best of our knowledge, no case been reported as a consequence of cholesteatoma. Our patient's recurrent cholesteatoma was intimately associated with a dehiscent tympanic segment of the fallopian canal and an exposed facial nerve, which led to his progressive hemifacial spasm.
Hemifacial spasm is a clinical diagnosis. Most patients present with progressive paroxysmal contraction of the muscles of facial expression. In its primary form, patients often first experience spasms of the zygomatic and temporal branches of the facial nerve, with relative sparing of the buccal and marginal mandibular distribution. The disease eventually progresses to involve all branches. This is in stark contrast to the secondary form, which almost always presents initially in all distributions of the facial nerve.
Other otolaryngologic symptoms that may be present include tinnitus in association with myoclonic contraction of the stapedius muscles and hearing loss secondary to the primary lesion. The differential diagnosis includes blepharospasm, focal cortical seizure, motor tics, and tardive dyskinesia.
The treatment of primary hemifacial spasm has changed since the introduction of therapeutic botulinum toxin. In the past, surgical intervention with craniotomy and vascular decompression was the treatment of choice. 3 This modality was associated with success rates as high as 90% in some series, although it also has the potential to cause significant morbidity and mortality, and recurrences are not uncommon. 4 It is currently reserved for patients who do not derive benefit from botulinum toxin injection or who prefer a permanent cure.
Pharmacotherapy with anticonvulsants, antipsychotics, and muscle relaxants has been tried with varying degrees of success, but it is limited by the negative side-effect profile of these agents.
Today, the gold standard of treatment for primary hemifacial spasm is botulinum toxin injection. Success rates have ranged from 75 to 100%. 5 Therapy is typically administered at 3-month intervals, but it may need to be more frequent depending on patient specifics.
All these modalities are also available for use in secondary hemifacial spasm, but treatment often is focused on the underlying cause. Our patient's middle ear exploration and removal of cholesteatoma resulted in a complete resolution of his spasms.
In conclusion, hemifacial spasm is a rare entity that may be encountered by otolaryngologists. A comprehensive history and physical examination must be obtained to identify any otolaryngologic causes of secondary hemifacial spasm. Middle ear pathology in conjunction with a dehiscent tympanic segment of the fallopian canal can precipitate spasm. Treatment is aimed at addressing the underlying pathology; if resolution is not achieved, treating the spasm with botulinum toxin is indicated.
